Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and ...

Moderna has settled related lawsuits that accused it of misusing Alnylam Pharmaceuticals' patented technology in its COVID-19 ...

Moderna (MRNA) and Alnylam (ALNY) resolve a patent dispute related to the technology used in former's COVID-19 vaccine. Read ...

While mRNA changed the game in vaccines, leveraging the technology to develop treatments has been trickier to navigate.

In the most recent trading session, Moderna (MRNA) closed at $25.51, indicating a +2.03% shift from the previous trading day.

After swiftly developing its COVID-19 vaccine in 2020 and launching it late that year, Moderna soon found itself facing ...

Vinay Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), has also been particularly outspoken ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Moderna’s new Laval-based facility supports onshore vaccine production, bolsters health and economic resilience, and ...

On Friday, a CDC advisory panel unanimously recommended limiting the Covid shot to people 65 and older or those with ...

Moderna stock toppled Friday after advisors to the CDC and Prevention ended the universal recommendation for Covid vaccines.